HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

beta-lactamase CMY-2

CMY-30 is a mutant of CMY-2 in which glycine replaces valine at position 211; enzyme responsible for cephamycin resistance; isolated from Klebsiella pneumoniae cefoxitin-resistant strain; amino acid sequence given in first source; GenBank X91840
Also Known As:
CMY-2 beta-lactamase; CMY-2 cephalosporinase; CMY-30 beta-lactamase, Citrobacter freundii; bla(CMY-2); bla-CMY-2; cephamycinase bla(CMY-2)
Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Babouee Flury, Baharak: 1 article (01/2020)
2. Buetti, Niccolo: 1 article (01/2020)
3. Casanova, Carlo: 1 article (01/2020)
4. Furrer, Hansjakob: 1 article (01/2020)
5. Jent, Philipp: 1 article (01/2020)
6. Livermore, David M: 1 article (01/2020)
7. Lo Priore, Elia: 1 article (01/2020)
8. Pelzer, Niklas: 1 article (01/2020)
9. Fung, Chang-Phone: 1 article (08/2015)
10. Lin, Tzu-Lung: 1 article (08/2015)

Related Diseases

1. Pneumonia (Pneumonitis)
2. Prostatitis
3. Liver Abscess
4. Infections

Related Drugs and Biologics

1. Porins
2. Imipenem
3. Cefepime (Maxipime)
4. Ceftriaxone (Ceftriaxon)
5. Tigecycline (Tygacil)